NCT06919198

The Dreamy Jet Study

Procedural Sedation for Minor Procedures Using Jet-Injected Subcutaneous Ketamine

• Status: Withdrawn
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Wisconsin, Madison · Academic / Other
• Sex: All
• Age: 2 Years – 15 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to see if a device known as a jet-injection system can help deliver a single dose of a sedating medication with less pain and stress than current methods. Participants will receive a dose of the sedative in their arm or thigh before their procedure at the sedation clinic.

Detailed description

This study will evaluate whether jet-injected ketamine can provide adequate sedation to perform minimally invasive procedures in children with heightened procedural sensitivity in a pediatric sedation clinic environment. Minimally invasive procedures include, but are not limited to, blood draws, IV placement, and immunizations.

Conditions

• Sedation
• Blood Drawing Procedure
• Immunization
• IV Placement

Interventions

Type	Name	Description
DRUG	Ketamine	ketamine 2.5 mg/kg

Timeline

• Start date: 2025-09-01
• Primary completion: 2028-08-01
• Completion: 2028-08-01
• First posted: 2025-04-09
• Last updated: 2025-08-12

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study